Akebia Therapeutics
AKBA
AKBA
76 hedge funds and large institutions have $58M invested in Akebia Therapeutics in 2023 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 19 increasing their positions, 21 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
10% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 21
4% less funds holding
Funds holding: 79 → 76 (-3)
30% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 10
Holders
76
Holding in Top 10
1
Calls
$1.61M
Puts
$276K
Top Buyers
| 1 | +$1.19M | |
| 2 | +$485K | |
| 3 | +$425K | |
| 4 |
Citigroup
New York
|
+$174K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$139K |
Top Sellers
| 1 | -$359K | |
| 2 | -$330K | |
| 3 | -$323K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$270K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$229K |